EAU Baltic Meeting - Renginiai, konferencijos, LUD · . ... 16.15 Course 1 Chair: P. Chlosta, Cracow (PL) Tutors: P. Baum, ... 18.45 Poster session 1: Prostate cancer I Chairs: B

Programme

European Association of Urology

EAU meetings and courses are accredited by the EBU in compliance with the UEMS/EACCME regulations

EAU Baltic Meeting 23-25 May 2014

Vilnius, Lithuania

http://eaubaltic.uroweb.org

AbstractsThe accepted abstracts of the EAU Regional Meetings are going to be published online by Elsevier as an official supplement of European Urology. This supplement will be online as of 1 July 2014 at www.sciencedirect.com.The abstracts will also be online at http://eaubaltic2014.uroweb.org/. The abstracts are documented in an international online journal and can be cited, providing proof of the academic productivity of the regions.

AccreditationThe ‘EAU Baltic Meeting’ is accredited by the European Accreditation Council for Continuing Medical Education (EACCME) to provide the following CME activity for medical specialists. The EACCME is an institution of the European Union of Medical Specialists (UEMS), www.uems.net.

The ‘EAU Baltic Meeting’ is designated for a maximum of 12 hours of European external CME credits. The EACCME credit system is based on 1 ECMEC per hour with a maximum of 3 ECMECs for half a day and 6 ECMECs for a full-day event. Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.

Through an agreement between the European Union of Medical Specialists and the American Medical Association, physicians may convert EACCME credits to an equivalent number of AMA PRA Category 1 Credits™. Information on the process to convert EACCME credit to AMA credit can be found at www.ama-assn.org/go/internationalcme.

Live educational activities, occurring outside of Canada, recognized by the UEMS-EACCME for ECMEC credits are deemed to be Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certification Program of The Royal College of Physicians and Surgeons of Canada.

Certificate of attendanceDelegates who have attended the meeting can print their certificate of attendance online through http://eaubaltic2014.uroweb.org/ using the barcode on the badge. This option is available as of Wednesday, 28 May 2014.

ExhibitionThe local organising committee has invited pharmaceutical companies, manufacturers of technical equipment and software as well as publishers of scientific books to exhibit their products at the exhibition organised at the meeting venue.

General Information

2 EAU Baltic Meeting

10.00 – 14.00 Registrations

14.00 – 14.05 Welcome B. Djavan, Vienna (AT) F. Jankevicius, Vilnius (LT) M. Jievaltas, Kaunas (LT)

14.05 – 14.15 The EAU Regional Office B. Djavan, Vienna (AT)

14.15 – 14.45 EAU Lecture A contemporary update on regenerative medicine - techniques as applied to the

lower urinary tract. C.R. Chapple, Sheffield (GB)

14.45 – 15.45 How to do and prepare a presentation J. Palou, Barcelona (ES)

15.45 – 16.50 Session 1 The role of prostatic biopsy in cancer detection and management Chairs: B. Djavan, Vienna (AT) M. Jievaltas, Kaunas (LT)

15.45 – 16.00 The indications, techniques, and limitations of current PB techniques and evolving techniques

B. Djavan, Vienna (AT)

16.00 – 16.15 New risk stratification tools M. Kincius, Kaunas (LT)

16.15 – 16.30 New diagnostic tools in prostate cancer: ESOU Lecture B. Djavan, Vienna (AT)

16.30 – 16.50 Discussion

16.50 – 17.15 State-of-the-art Urine biomarkers for diagnosis of bladder cancer B.J. Schmitz-Dräger, Fürth (DE)

Programme Friday, 23 May 2014

323-25 May 2014


17.15 – 17.45 Coffee break and poster viewing

17.45 – 18.45 Poster Session 1: Prostate cancer I Room: Lambda Chairs: B. Djavan, Vienna (AT) F. Jankevicius, Vilnius (LT)

Poster Session 2: Female urology, infectious diseases, infertility, sexual dysfunction and urothelial tumours

Room: Zeta Chairs: C.R. Chapple, Sheffield (GB) T. Tamm, Tallinn (EE)

19.00 Welcome reception



ESUT Hands-on training LaparoscopyIndustry sponsored

Course director: J. Rassweiler, Heilbronn (DE)

Course Coordinators: P. Chlosta, Cracow (PL) J-T. Klein, Heilbronn (DE)

Format: Introduction by course coordinator (15 minutes) Hands-on-training at different models (80 minutes) Questions and answers, tips and tricks (25 minutes)

Room: Beta

14.15 - 16.15 Course 1 Chair: P. Chlosta, Cracow (PL) Tutors: P. Baum, Tallinn, (EE) M. Jievaltas, Kaunas (LT) D. Milonas, Kaunas (LT)

16.45 - 18.45 Course 2 Chair: P. Chlosta, Cracow (PL) Tutors: P. Baum, Tallinn, (EE) M. Jievaltas, Kaunas (LT) D. Milonas, Kaunas (LT)

Aims and objectivesLaparoscopic procedures are continuously evolving in urology based on the increasing expertise of urologic surgeons. This includes ablative procedures, such as radical nephrectomy as well as reconstructive techniques, such as pyeloplasty. Some advanced procedures (i.e. radical prostatectomy, radical cystectomy) have both, ablative and reconstructive steps. Since the number of centres with laparoscopic expertise is still limited in Europe, laparoscopic training programmes have become very important. Hands-on training courses at the pelvi-trainer represent one of the main steps of such courses. Finally, all remaining questions can be answered and discussed with all tutors including the demonstration of tips and tricks.

You can register at the EAU registration desk.

523-25 May 2014

Programme Saturday, 24 May 2014

09.00 – 11.00 Session 2 Castration resistant metastatic prostate cancer: Where we are in 2014 Chairs: F.M.J. Debruyne, Arnhem (NL) T. Tamm, Tallin (EE)

09.00 – 09.15 New insights in the mechanism of castration resistance: What is important to know for practicing physicians

J.P.M. Sedelaar, Nijmegen (NL)

09.15 – 09.30 Face the challenge of determining the optimal sequencing of these new agents F.M.J. Debruyne, Arnhem (NL)

09.30 – 09.45 Androgen blockade re-engagement: Targeting AR and androgen synthesis in adrenal glands and peripheral tissues.

F. Jankevicius, Vilnius (LT)

09.45 – 10.00 Taxane chemotherapy: When to start and optimal sequence A. Cesas, Klaipeda (LT)

10.00 – 10.15 Bone targeting: Bisphosphonates, RANK inhibitors or alpha-emitters K. Ojamaa, Talinn (EE)

10.15 – 10.30 Treatment response/disease progression evaluation P. Vaganovs, Riga (LV)



11.30 – 12.30 Poster session 3: BPH, male incontinence, neuro-urology, penis/testis, trauma, urethral stricture and uro-genital reconstruction

Room: Lambda Chairs: P. Baum, Tallinn (EE) V. Lietuvietis, Riga (LV)

Poster session 4: Prostate cancer II Room: Zeta Chairs: J.P.M. Sedelaar, Nijmegen (NL) E. Vjaters, Riga (LV)



12.30 – 13.00 State-of-the-art lecture Targeted pharmacotherapy of urolithiasis: Is it reality? O.W. Hakenberg, Rostock (DE)

13.00 – 14.00 Lunch and Meet the Masters

14.00 – 16.30 ESU Course Update in renal cancer Chair: J. Palou, Barcelona (ES)

14.00 – 14.05 European School of Urology: A unique possibility for urological education J. Palou, Barcelona (ES)

14.05 – 14.30 Nephron sparing surgery: Where is the limit? J. Palou, Barcelona (ES)

14.30 – 14.45 Active surveillance and minimally invasive treatments in renal cancer L. Türkeri, Istanbul (TR)

14.45 – 15.30 Radical treatment in advanced disease: When do we have to stop? J. Palou, Barcelona (ES)

15.30 – 16.00 What s true and useful with Tyrosin kinase inhibitors treatment in metastatic renal cancer

L. Türkeri, Istanbul (TR)

16.00 – 16.30 Interactive case discussion ESU Faculty D. Trumbeckas and A. Patasius, Kaunas (LT) M. Barisiene, Vilnius (LT)

723-25 May 2014


16.30 – 17.30 Symposium Avanafil a new PDE-5 inhibitor Chair: B. Djavan, Vienna (AT)

Introductory remarks on PDE-5 inhibitors B. Djavan, Vienna (AT)

Efficacy of Avanafil - an overview K. Pomm, Tallinn (EE)

What is new in Avanafil comparing to other PDE-5 inhibitors? R. Adomaitis, Vilnius (LT)

Is Avanafil offering a new safety profile (PDE-5 selectivity)? P. Vaganovs, Riga (LV)

Conclusion remarks B. Djavan, Vienna (AT)

Industry sponsored


18.00 – 19.00 Poster session 5: Paediatric urology, stones and varia Room: Lambda Chairs: O.W. Hakenberg, Rostock (DE) M. Jievaltas, Kaunas (LT)

Poster session 6: Renal tumours, kidney tumours, adrenals and kidney transplantation

Room: Zeta Chairs: L. Kukk, Talinn (EE) J. Palou, Barcelona (ES)

20.00 Congress dinner



ESUT/EULIS Hands-on training UreterorenoscopyIndustry sponsored

Course director: J. Rassweiler, Heilbronn (DE)

Course Coordinators: P. Chlosta, Cracow (PL) J-T. Klein, Heilbronn (DE)

Format: Introduction by course coordinator (15 minutes) Hands-on- Training at different models (75 minutes) Questions and answers, Tips and Tricks (30 minutes)

Room: Beta

09.00 – 11.00 Course 1 Chair: J-T. Klein, Heilbronn (DE) Tutors: S. Gaizauskas, Vilnius (LT) A. Szendröi, Budapest (HU) A. Zelvys, Vilnius (LT)

11.30 – 13.30 Course 22 Chair: J-T. Klein, Heilbronn (DE) Tutors: S. Gaizauskas, Vilnius (LT) A. Szendröi, Budapest (HU) A. Zelvys, Vilnius (LT)

Aims and objectivesThe European Society of Uro-Technology (ESUT) and the EAU Section of Urolithiasis (EULIS) offer an intensive hands-on training course with different models focussing on the endoscopic management of urolithiasis. The delegates will be taken through a sequential programme of Ureterorenoscopy using normal endoscopic instruments in different models. The use of various guide-wires, baskets and intracorporeal lithotripters will be demonstrated. The ESUT and the EULIS faculty consist of experienced surgeons in the field of Ureterorenoscopy. A video demonstrating the different steps and tasks of the procedures will be presented and afterwards the delegates will be instructed according to their level of experience in small teams at the models. Finally, all remaining questions can be answered and discussed with all tutors including the demonstration of tips and tricks.

You can register at the EAU registration desk.

923-25 May 2014

09.00 – 09.30 Best Poster Awards B. Djavan, Vienna (AT) F. Jankevicius, Vilnius (LT) The award winners should present their presentation Industry sponsored

09.30 – 10.00 State-of-the-art lecture Surgical treatment options for male stress urinary incontinence C.R. Chapple, Sheffield (GB)

10.00 – 10.30 BPH Lecture F.M.J. Debruyne, Arnhem (NL) Industry sponsored

10.30 – 11.50 Session 3 The progress in endourology Chairs: E. Vjaters, Riga (LV) C.R. Chapple, Sheffield (GB)

10.30 – 10.45 New optical imaging technologies for bladder cancer: Considerations and perspectives

J. Palou, Barcelona (ES)

10.45 – 11.15 Endoscopic management of upper tract pathology: Urothelial cancer, ureteral strictures and secondary ureteropelvic junction obstruction

O.W. Hakenberg, Rostock (DE)

11.15 – 11.30 Endoscopic combined intrarenal surgery (ECIRS) - a new approach for the treatment of large and complex urolithiasis

A. Zelvys, Vilnius (LT)


11.50 – 12.15 Coffee break

Programme Sunday, 25 May 2014


12.15 – 12.30 Fellowship programs of the EUSP B. Djavan, Vienna (AT)

12.30 – 12.45 EAU Young Urologists Office: What can the EAU do for you? J.P.M. Sedelaar, Nijmegen (NL)

12.45 – 12.50 Farewell F. Jankevicius, Vilnius (LT)

12.50 – 12.55 Closing remarks B. Djavan, Vienna (AT)

Programme Sunday, 25 May 2014

1123-25 May 2014

Poster session 1

Friday, 23 May 2014

17.45 - 18.45 Poster session 1: Prostate cancer I Chairs: B. Djavan, Vienna (AT) F. Jankevicius, Vilnius (LT)Room: Lambda

B01 WithdrawnB02 Pre-operative training induced histomorphometric changes and function on pelvic floor muscle in patients undergoing

radical prostatectomyR. Ramirez-Velez, A. Ocampo-Trujillo, C.A. Muñoz (Bogotá D.c, Cali, Colombia)

B03 Influence of various factors on survival in patients with biochemical recurrence after radical prostatectomyA. Andabekov, D. Prokhorov, M. Shkolnik, V. Metelev (Sankt-Petersburg, Russia)

B04 Hypofractionated salvage radiotherapy for recurrence prostate cancer after radical prostatectomyP.V. Bulychkin, S.I. Tkachev, A.V. Berdnik, A.V. Zavistovsky, Y.B. Bykova, I.N. Kurganova (Moscow, Russia)

B05 Does length of prostate biopsy cores impact in diagnosis of prostate cancer?M. Ergün, E. Islamoglu, S. Yalçınkaya, H. Tokgöz, M. Savas (Antalya, Turkey)

B06 WithdrawnB07 Analysis of single nucleotide polymorphisms in RNASEL, LEPR, CRY1, IL4 and CHI3L2 genes in a cohort of Lithuanian

prostate cancer and benign prostatic hyperplasia patientsŽ. Kapustina, G. Valaitiene, K. Daniunaite, S. Jarmalaite, F. Jankevicius, A. Laurinavicius, J.R. Lazutka (Vilnius, Lithuania)

B08 Hormono-radiotherapy with or without concurrent chemotherapy in locally-advanced prostate cancerS.L. Polyakov, O.G. Sukonko, A.I. Rolevich, I.I. Minailo, O.I. Moiseeva, E.L. Slobina (Minsk, Belarus)

B09 First clinical experience in salvage prostate cryotherapy – Presentation of 5 casesA. Ulys, A. Vezelis, Ž. Kardelis, R. Grigiene (Vilnius, Lithuania)

B10 Randomized prospective study of adjuvant hormonal therapy for high risk prostate cancer after radical prostatectomyA. Patasius, M. Kincius, A.J. Matjošaitis, D. Trumbeckas, D. Milonas, M. Jievaltas (Kaunas, Lithuania)

B11 Is asymmetric lobe finding in digital rectal examination a risk factor for prostate cancer?Ö. Yılmaz, Z. Aktas, H. Soydan, F. Ates, E. Malkoç (Istanbul, Turkey)

B12 Clinical and prognostic values of the pretreatment PSA doubling time in patients with prostate cancerO. Bogomolov, G. Zharinov (Saint-petersburg, Russia)

B13 Autopsy- and biopsy-verified criteria for identifying Cowper’s glands using ultrasoundA. Golab, B. Wiszniewska, M. Slojewski, M. Puszynski, A. Sikorski (Szczecin, Poland)

B14 First clinical experience in transperineal biopsy of prostateZ. Kardelis, A. Ulys, A. Vezelis (Vilnius, Lithuania)

B15 The role of Gleason score on survival of locally advanced (pT3) prostate cancer after radical prostatectomyD. Milonas, G. Peciulyte, T. Simaska, M. Kincius, I. Gudinaviciene, G. Smailyte, M. Jievaltas (Kaunas, Lithuania)


Poster session 2

Friday, 23 May 2014

17.45 - 18.45 Poster session 2: Female urology, infectious diseases, infertility, sexual dysfunction and urothelial tumours

Chairs: C.R. Chapple, Sheffield (GB) T. Tamm, Tallinn (EE)Room: Zeta

B16 Combination of chronic cystitis and chronic endometritis in women combination of chronic cystitis and chronic endometritis in womenA. Neimark, N. Shelkovnikova, R. Aliev (Barnaul, Russia)

B17 Mixed form of urinary incontinence and estrogen deficiency in womenA. Neimark, M.V. Razdorskaya, R. Aliev (Barnaul, Russia)

B18 Comparison of three surgical approaches for the treatment of female recurrent stress urinary incontinenceA. Cerniauskiene, M. Barisiene, F. Jankevicius, G. Januska (Vilnius, Lithuania)

B19 Evaluation of LRINEC scale feasibility in predicting outcomes of Fournier gangreneM. Kincius, A. Preidis, T. Telksnys, D. Trumbeckas, M. Jievaltas, D. Milonas (Kaunas, Lithuania)

B20 WithdrawnB21 Ultrastructural study of sperm morphology has the important prognostic value in evaluation of the outcome of the assisted

reproductive techniques in cases caused by male infertilityM.N. Korshunov, E.S. Korshunova, I.V. Vinogradov (Moscow, Russia)

B22 Associations between asymptomatic prostatitis and erectile dysfunction in middle-aged malesK. Ausmees (Tartu, Estonia)

B23 Selection criteria for second transurethral resection in nonmuscle-invasive bladder cancer patients at high risk for residual tumorA.I. Rolevich, O.G. Sukonko, S.A. Krasny, S.L. Polyakov, T.I. Nabebina, A.A. Minich (Minsk, Belarus)

B24 Long-term risk of upper urinary tract recurrence after organ-preserving therapy of nonmuscle-invasive bladder cancerA.I. Rolevich (Minsk, Belarus)

B25 WithdrawnB26 Diagnosis and treatment of urinary schistosomiasis as pre-condition of bladder cancer

V. Startsev, A. Kolmakov (St. Petersburg, Russia; Lobito, Angola)B27 Advanced bladder cancer at woman in the third trimester of pregnancy

V. Startsev (St. Petersburg, Russia)B28 Surgical implication of clinical presentation of low differentiated urothelial bladder cancer

P. Yakovlev, A. Kondratenko, V. Mrachkovsky, A. Sakalo, Y. Kuranov (Kiev, Ukraine)B29 Impact of regional lymph node status on cancer-specific survival in muscle-invasive bladder cancer patients with high risk

of progressionA. Minich, A. Zhegalik, A. Poluyanchik, V. Vasilevich, A. Rolevich, S. Polyakov, S. Krasny, O. Sukonko (Minsk, Belarus)

B30 Survival after radical cystectomy for patients with bladder cancer: Long term outcomes of single institutionT. Simaska, D. Milonas, A. Rakauskas, A. Chamsin, L. Citvaras, M. Kincius, I. Gudinaviciene, G. Smailyte, M. Jievaltas (Kaunas, Lithuania)

B31 TURBT as a possible method for treating patients with infiltrative tumors at staging T3a and T3bI. Haxhiu, X. Quni, A. Haxhiu, H. Arifi, E. Haxhiu, H. Ahmeti, R. Haxhiu (Prishtina, Kosovo)

1323-25 May 2014

Poster session 3

Saturday, 24 May 2014

11.30 - 12.30 Poster session 3: BPH, male incontinence, neuro-urology, penis/testis, trauma, urethral stricture and uro-genital reconstruction

Chairs: P. Baum, Tallinn (EE) V. Lietuvietis, Riga (LV)Room: Lambda

B32 Effectivness of treatment with alfa-blokers and herbal selections in elder BPH patientsV. Kamarauskas (Vilnius, Lithuania)

B33 Bioequivalence of a fixed-dose combination compared to a free-dose combination of dutasteride/tamsulosin hydrochlorideM. Teleshinin, A. Vinarov, V. Danovich, S. Udotova, V. Bulatov (Reutov, Moscow, Russia)

B34 The first experience in Laparoscopic Retropubic Simple ProstatectomyR. Jankovski, D.S. Sukys (Vilnius, Lithuania)

B35 First outcomes of implanting Argus® adjustable male sling in treatment of male urinary incontinenceA. Cerniauskiene, F. Jankevicius, M. Snicorius, L. Andreika (Vilnius, Lithuania)

B36 Early diagnosis and referral of Prostate Pain Syndrome to pain teams – a partnership in progressA. Beverly, S. Graham, A. Ghazi (London, United Kingdom)

B37 Comparison of conantokin G (CTG)-induced changes in the chemical coding of dorsal root ganglia (DRG) neurons supplying porcine urinary bladder with changes induced by resiniferatoxin (RTX), tetrodotoxin (TTX) and botulinum toxin A (BTX)A. Bossowska, E. Lepiarczyk, P. Radziszewski, M. Majewski (Olsztyn, Warsaw, Poland)

B38 The distribution and chemical coding of sympathetic chain neurons supplying the wall of the urinary bladder in normal female pigs and in the pigs after intravesical administration of botulinum toxin (BTX)E. Lepiarczyk, A. Bossowska, U. Mazur, M. Majewski (Olsztyn, Poland)

B39 Metachronous testicular seminoma with an interval of 8 years from the first seminomatous testicular tumor: A case reportX. Cuni, I. Haxhiu, M. Xhani, H. Aliu-Cuni, L. Cuni (Prishtina, Kosovo; Tirana, Albania)

B40 Diagnostic test in men with premature ejaculation for selective neurotomy of the penisR. Aliev, A. Neimark, A. Erkovich, S. Vybornov (Barnaul, Novosibirsk, Astrakhan, Russia)

B41 Gangrene of the penis in a diabetic male with amputations of both extremitasXh. Cuni, I. Haxhiu, M. Xhani, F. Tartari, S. Mehmeti, A. Fetahu, M. Oruqi (Pristina, Prishtina, Kosovo; Tirana, Albania)

B42 Urgent urologic traumaA. Neziri (Prishtina, Kosovo)

B43 A 17-years experience of renal injury at a tertiary level hospitalT. Telksnys, D. Trumbeckas, A.J. Matjošaitis, M. Jievaltas, D. Milonas, M. Kincius (Kaunas, Lithuania)

B44 Is urethrotomy still the first choice in urethral stricture management?A. Grybas, L. Andreika, E. Starolis (Vilnius, Lithuania)

B45 Tunica vaginalis flap in one stage hypospadias reconstructionV.A.P. Pagkalos, C.G. Georgiadis, S.B. Bolomytis, K.I. Ioannidis, A.A. Archontakis (Athens, Greece)

B46 Outcomes of robotic dismembred pyeloplastyK. Ener, S. Altinova, A.E. Canda, M.F. Ozcan, E. Asil, E. Urer, A.F. Atmaca, Z. Akbulut (Ankara, Turkey)


Poster session 4


11.30 - 12.30 Poster session 4: Prostate cancer II Chairs: J.P.M. Sedelaar, Nijmegen (NL) E. Vjaters, Riga (LV)Room: Zeta

B47 The role of PSA for prostate cancer detection in patients with high grade intraepithelial neoplasiaD. Milonas, G. Skulcius, S. Auskalnis, I. Gudinaviciene, M. Jievaltas (Kaunas, Lithuania)

B48 Survival after radical prostatectomy and external beam radiotherapy for patients with high risk prostate cancer: Results of single tertiary referral hospitalR. Mickevicius, D. Milonas, L. Mickevicvius, G. Peciulyte, L. Jarusevicius, M. Kincius, S. Auskalnis, T. Simaska, I. Gudaniviciene, G. Smailyte, M. Jievaltas (Kaunas, Vilnius, Lithuania)

B49 Salvage high dose rate prostate brachytherapy - alternative treatment for prostate cancer recurrence after radiotherapyA. Ivanauskas, A. Veželis, A. Burneckis, A. Ulys (Vilnius, Lithuania)

B50 Long term outcomes after radical prostatectomy for patients suitable for active surveillanceM. Kincius, J. Verikaite, G. Smailyte, M. Jievaltas, D. Milonas (Kaunas, Vilnius, Lithuania)

B51 Non-invasive methods (HistoScanning and multiparametric MRI) for diagnosis of prostate cancerI. Naruseviciute, A. Ulys, R. Briediene, A. Vezelis, R. Grigiene, M. Trakymas (Vilnius, Lithuania)

B52 Characteristics of endovideosurgical radical prostatectomy using extraperitoneal approach: Analysis of 70 casesM. Borisenkov, S.V. Popov, I.N. Orlov, P.V. Vyazovtsev (Saint-Petersburg, Russia)

B53 Formation of vesicourethral anastomosis after laparoscopic extraperitoneal radical prostatectomy: Comparative analysis of three different techniquesM. Borisenkov, S.V. Popov, I.N. Orlov, P.V. Vyazovtsev (Saint-Petersburg, Russia)

B54 First results of prostate cancer screening programme in BelarusO. Sukonko, S. Krasny, D. Tarend (Minsk, Belarus)

B55 Complications rate after early prostate cancer treatment with I-125 seedsK. Vaiciunas, L. Jarusevicius, A. Inciura, J. Babakinas, E. Juozaityte, M. Jievaltas (Kaunas, Lithuania)

B56 Five years experience of prostate cancer treatment using I-125 interstitial prostate brachytherapy: Complications and long term resultsA. Rimas, F. Jankevicius (Vilnius, Lithuania)

B57 Focal MR-guided focused ultrasound treatment of localized low-risk prostate cancerA. Nosov, V. Turkevich, S. Petrov, A. Vorobiev, S. Kanaev, G. Gafton, R. Novikov (Saint-Petersburg, Russia)

B58 Evaluation of tumour-associated autoantibody signature for the diagnosis of prostate cancerZ. Kalnina, V. Lietuvietis, L. Sadovska, P. Zayakin, G. Sperga, K. Silina, K. Miculis, A. Line (Riga, Latvia)

B59 Safety, objective response rate and long-term oncologic outcomes of docetaxel neoadjuvant chemotherapy followed by radical prostatectomy for patients with intermediate- and high-risk prostate cancer: a retrospective single-center studyA. Nosov, S. Petrov, S. Reva, E. Mamijev, R. Novikov (Saint-Petersburg, Russia)

B60 Trends in incidence and mortality of urologic cancers in Latvia, 2000-2012I. Kukulis, E. Liepina, S. Pildava, A. Meniss, I. Zamullo, V. Lietuvietis (Riga, Latvia)

1523-25 May 2014

Poster session 5


18.00 - 19.00 Poster session 5: Paediatric urology, stones and varia Chairs: O.W. Hakenberg, Rostock (DE) M. Jievaltas, Kauno Rajonas (LT)Room: Lambda

B61 Deviation of the penoscrotal median raphe: Is it a normal finding or within the spectrum of hypospadias?A. Mohan, L. Ashton, M. Dalal (Preston, United Kingdom)

B62 Re-do operations in adults operated for proximal hypospadias in childhoodY. Rudin, T.N. Garmanova, D.V. Marukhnenko (Moscow, Russia)

B63 Diagnosis and treatment of hydronephrosis in infantsK. Iodkovsky, A.V. Hmelenko (Grodno, Belarus)

B64 Experience of peritoneal dialysis in children with sepsis-induced acute kidney injury in postoperative periodV. Sergienko, A.V. Hmelenko, R. Yakubtsevich, K. Bushma, V. Kazhina, A. Klochko (Grodno, Belarus)

B65 Management of bladder stones with transurethral pneumatic cystolithotripsyX. Cuni, I. Haxhiu, M. Xhani, H. Aliu-Cuni, P. Nuraj, S. Mehmeti, E. Isaku (Pristina, Prishtina, Kosovo; Tirana, Albania)

B66 Stone in an orthotopic system ureterocele: Low and short smiling incision technique with the extraction of calculusH. Tokgoz, S. Yalcinkaya, M. Savas, O. Tokgoz, E. Islamoglu (Antalya, Ankara, Turkey)

B67 WithdrawnB68 WithdrawnB69 Heat treatment value in X-ray phase analysis of urinary calculi: Experience of 1000 cases

V. Sknar, I. Aboian, V. Nalbandyan, I. Shukaev, D. Zolotukhin (Rostov-on-don, Russia)B70 Laparoscopic ureterolithotomy and pyelolithotomy: 6 years experience in Vilnius city clinical hospital

D. Silinis, J. Sabalys, E. Štarolis, A. Gradauskas, L. Andreika, S. Moceviciene (Vilnius, Lithuania)B71 Role of combined intrarenal surgery (ECIRS) in management of large/complex kidney stones

A. Zelvys, A. Cekauskas, F. Jankevicius (Vilnius, Lithuania)B72 Establishment of andrological services in remote Regions of the Russian Federation

R. Aliev, A. Neimark, E. Subbotin, T. Nasedkina (Barnaul, Russia)B73 Caffeic acid phenethyl ester (CAPE) ameliorates ischemia-induced renal mitochondrial injury in rats

S. Trumbeckaite, R. Baniene, M. Jievaltas, D. Trumbeckas, M. Kincius (Kaunas, Lithuania)B74 Early thrombosis of arteriovenous fistula in patients on chronic dailysis: Incidence and risk factors

L. Rimsevicius, S. Strainiene, T. Strainys, R. Tyla, A. Zelvys, L. Supranaviciene, F. Jankevicius, M. Miglinas (Vilnius, Lithuania)


Poster session 6


18.00 - 19.00 Poster session 6: Renal tumours, kidney tumours, adrenals and kidney transplantation

Chairs: L. Kukk, Tallinn (EE) J. Palou, Barcelona (ES)Room: Zeta

B75 Retroperitoneal laparoscopic treatment of phaeochromocytomasR. Rabii, A. Halfya (Casablanca, Morocco)

B76 Incidence and search for new risk factors of urinary tract infection in renal transplant recipientA. Kalachyk, A. Narbin, P. Vershinin, M. Guberskaya, M. Kozlova, E. Oganova (Minsk, Belarus)

B77 ABO incompatibility does not have an influence on early kidney graft survival in living related donor transplantationL. Rimsevicius, I. Maliukeviciute, D. Alekniene, E. Asakiene, L. Griskevicius, A. Griskevicius, A. Zelvys, F. Jankevicius, M. Miglinas (Vilnius, Lithuania)

B78 Analysis of infections requiring hospitalization in a cohort of renal allograft recipientsL. Rimsevicius, R. Steponaviciute, D. Alekniene, E. Asakiene, A. Zelvys, F. Jankevicius, M. Miglinas (Vilnius, Lithuania)

B79 Outcomes of robotic partial nephrectomyK. Ener, A.E. Canda, S. Altinova, E. Asil, M.F. Ozcan, A.F. Atmaca, Z. Akbulut (Ankara, Turkey)

B80 Lapraroscopy-assisted cryotherapy for small renal tumoursP. Baum, L. Kukk, E. Valk, Y. Zirel (Tallinn, Estonia)

B81 Percutaneous radiofrequency ablation of renal tumors: Efficacy, safety and post-operative survivalA. Ulys, M. Trakymas, A. Zalimas (Vilnius, Lithuania)

B82 R.E.N.A.L. nephrometry score as the possibility in choosing operative strategy in renal tumorsM. Markevicius, J. Vaiciuliene, A. Bakavicius, D. Rutkauskaite, A. Tamosiunas, F. Jankevicius (Vilnius, Lithuania)

B83 The prognostic role of blood markers in patients with renal cell carcinoma (RCC)I. Vaivode, S. Donina, V. Lietuvietis, M. Jakubovskis, Z. Vitenberga, D. Baltina (Riga, Latvia)

B84 The comparative analysis of the changes in immune response after laparoscopic radiofrequency ablation and resection of renal cancerE. Samarceva, S. Reva, A. Nosov (Saint-Petersburg, Russia)

B85 Predictive value of histologic pattern for early recurrence in patients with local advanced and metastatic renal cell carcinoma (RCC)I. Vaivode, M. Sperga, D. Baltina, S. Donina, D. Ulase, S. Gordins, M. Jakubovskis, S. Beketovs, V. Lietuvietis (Riga, Latvia)

B86 Application of LESS technologies in urological practiceT. Topuzov, S.V. Popov, I.N. Orlov, M.B. Borisenkov (Saint-Petersburg, Russia)

B87 Surgical and conservative management of small renal tumorsE. Štarolis, D. Silinis, A. Bakavicius, Z. Karvelis (Vilnius, Lithuania)

1723-25 May 2014

Do not missthe AwardSession!Prestigious awards for Best PosterPresentations will be handed out on thelast day of the meeting

• The awards will be presented at the end of the meeting by Prof. Bob Djavan and Prof. Feliksas Jankevicius

• The award winners will be selected on-site by the chairmen of the poster sessions.

• The award winners should present their presentation • The award-winning posters will be displayed in a specifically designated area

at the Annual EAU Congress• The award winners will be invited to present their poster at the 30th Annual

EAU congress in Madrid, 20-24 March 2015.

Industry sponsored

Sunday, 25 May 201409.00 hrsPlenary Room

Contributors

The EAU is very grateful for the support of the following contributors:

EXHIBITORS: ASTELLAS BAYER BERLIN-CHEMIE BIONORICA GSK IPSEN JANSSEN KARL STORZ GMBH & CO.KG LILLY OLYMPUS PFIZER ROCHE SANOFI SORMEDICA VIASANA

1923-25 May 2014

MADRID20-24 March 2015

Sharing knowledge - Raising the level of urological care

#EAU15

European Association of Urology

��

30th Anniversary Congresswww.eaumadrid2015.org

Documents

EAU Baltic Meeting - Renginiai, konferencijos, LUD · . ... 16.15 Course 1 Chair: P. Chlosta, Cracow (PL) Tutors: P. Baum, ... 18.45 Poster session 1: Prostate cancer I Chairs: B